A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases
- PMID: 25378989
- PMCID: PMC4213864
- DOI: 10.1016/j.jgr.2014.03.001
A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases
Abstract
Ginseng is widely used for its promising healing and restorative properties as well as for its possible tonic effect in traditional medicine. Nowadays, many studies focus on purified individual ginsenoside, an important constituent in ginseng, and study its specific mechanism of action instead of whole-plant extracts on cardiovascular diseases (CVDs). Of the various ginsenosides, purified ginsenosides such as Rb1, Rg1, Rg3, Rh1, Re, and Rd are the most frequently studied. Although there are many reports on the molecular mechanisms and medical applications of ginsenosides in the treatment of CVDs, many concerns exist in their application. This review discusses current works on the countless pharmacological functions and the potential benefits of ginseng in the area of CVDs.
Results: Both in vitro and in vivo results indicate that ginseng has potentially positive effects on heart disease through its various properties including antioxidation, reduced platelet adhesion, vasomotor regulation, improving lipid profiles, and influencing various ion channels. To date, approximately 40 ginsenosides have been identified, and each has a different mechanism of action owing to the differences in chemical structure. This review aims to present comprehensive information on the traditional uses, phytochemistry, and pharmacology of ginseng, especially in the control of hypertension and cardiovascular function. In addition, the review also provides an insight into the opportunities for future research and development on the biological activities of ginseng.
Keywords: antioxidant effect; cardiovascular diseases; lipid profile; myocardial protection; vasomotor tone.
Figures
References
-
- Gielen S., Landmesser U. The Year in Cardiology 2013: cardiovascular disease prevention. Eur Heart J. 2014;35:307–312. - PubMed
-
- Tunstall-Pedoe H., Vanuzzo D., Hobbs M., Mähönen M., Cepaitis Z., Kuulasmaa K., Keil U. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet. 2000;355:688–700. - PubMed
-
- Toth P.P. Making a case for quantitative assessment of cardiovascular risk. J Clin Lipidol. 2007;1:234–241. - PubMed
-
- Libby P. Act local, act global: inflammation and the multiplicity of “vulnerable” coronary plaques. J Am Coll Cardiol. 2005;45:1600–1602. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
